Tardive dyskinesia (TD) is a movement disorder typically caused by taking neuroleptic drugs. Treatment focuses on preventing the recurrence or persistence of symptoms. Tardive dyskinesia (TD) most ...

Tracking your tardive dyskinesia symptoms provides insight into what’s going on. Tardive dyskinesia (TD) is a movement disorder that causes certain uncontrollable movements in different parts of the ...

According to 82.7% of the caregivers, TD severely impacted (score ≥ 4 on a scale of 1 to 5) patients on at least 1 item within each domain. For the physical impact, the mean score was 3.2 and was ...

Danielle Nicole Larson, MD, discusses the mental health burden on patients with tardive dyskinesia, and considerations for clinicians who manage this condition.

After 5 weeks of taking 300 mg of lithium daily, a 76-year-old woman with lurasidone-induced tardive dyskinesia from treatment for Bipolar II Disorder experienced reduced impact, intensity, and ...

This week, valbenazine became the first-ever drug approved by the Food and Drug Administration (FDA) for the treatment of tardive dyskinesia. Today, Psych Unseen answers some questions about the ...

Some studies suggest vitamin E may help ease symptoms of tardive dyskinesia — but how strong is the evidence, and what does it really tell us? Note: The U.S. Food and Drug Administration (FDA) does ...

The KINECT-PRO™ analysis is the first and only of its kind to report both remission of tardive dyskinesia symptoms and associated improvements in patient-reported outcomes. Post-hoc analysis from ...

SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) presented data from more than 300 patients diagnosed with tardive dyskinesia and treated with INGREZZA ® ...